BBHvsGDOCETF Comparison
VS
VanEck Biotech ETF (BBH) belongs to the US Health Care segment. Goldman Sachs Future Health Care Equity ETF (GDOC) is part of the Healthcare Technology segment. Both ETFs have the same top 1 sector exposures: Healthcare. BBH is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.75% for GDOC. BBH is up 32.7% year-to-date (YTD) with +$22M in YTD flows. GDOC performs worse with 11.35% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of BBH and GDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBH vs GDOC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 11/05/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBH GDOC | +4.37%+7.89% | +19.27%+10.62% | +32.70%+11.35% | +38.73%+15.40% | +68.11%+37.48% | +34.27%n/a |
| Flows | BBH GDOC | +$15M- | +$29M- | +$22M-$2M | +$24M-$2M | -$123M-$83M | -$126M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBH GDOC | +29.42%+16.81% | +22.89%+15.90% | +20.65%+15.06% | +21.87%n/a |
| Max drawdown | BBH GDOC | -6.32%-7.14% | -10.54%-15.39% | -22.78%-22.18% | -33.06%n/a |
| Max drawdown duration | BBH GDOC | 36d70d | 150d221d | 440d449d | 1456dn/a |
Trading data
BBH | GDOC | |
Last sale 11/5/2026 at 2:30 PM | $251.01 | $38.47 |
| Previous close 11/04/2026 | $261.63 | $39.69 |
| Consolidated volume 11/04/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of October 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GDOC
is actively managed and doesn’t replicate an indexBBH | GDOC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 11/5/2026 at 2:30 PM
Live
Closed
BBH | GDOC | |
|---|---|---|
| Last price | $251.01 | $38.47 |
| 1D performance | -4.06% | -3.06% |
| AuM | $518.81 M | $20.83 M |
| E/R | 0.35% | 0.75% |
Characteristics
BBH | GDOC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VanEck | Goldman Sachs |
| Benchmark | MVIS US Listed Biotech 25 Index | - |
| N° of holdings | 25 | 37 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 20, 2011 | November 11, 2021 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBH
USA
88.89%
Other
11.11%
GDOC
USA
83.64%
Other
16.36%
Sectors
BBH
Healthcare
100%
Other
-0%
GDOC
Healthcare
98.4%
Other
1.6%
Advertisement
Diversification
BBH
Total weight of top 15 holdings out of 15
85.93%
GDOC
Total weight of top 15 holdings out of 15
72.21%
Top 15 holdings
Data as of September 30, 2026
BBH
Amgen, Inc.
15.74%
Gilead Sciences, Inc.
13.28%
Vertex Pharmaceuticals, Inc.
8.21%
Regeneron Pharmaceuticals, Inc.
6.38%
Moderna, Inc.
6.35%
Natera, Inc.
5.31%
argenx SE
4.62%
IQVIA Holdings, Inc.
4.43%
Revolution Medicines, Inc.
4.17%
Illumina, Inc.
3.99%
Guardant Health, Inc.
2.97%
Alnylam Pharmaceuticals, Inc.
2.76%
BeOne Medicines Ltd.
2.74%
Biogen, Inc.
2.73%
Incyte Corp.
2.24%
GDOC
Eli Lilly & Co.
12.57%
Johnson & Johnson
8.54%
Merck & Co., Inc.
7.54%
UnitedHealth Group, Inc.
5.64%
Vertex Pharmaceuticals, Inc.
4.09%
Guardant Health, Inc.
4.02%
Agilent Technologies, Inc.
3.98%
argenx SE
3.88%
Thermo Fisher Scientific, Inc.
3.87%
DexCom, Inc.
3.70%
Edwards Lifesciences Corp.
3.33%
Intuitive Surgical, Inc.
3.18%
Lonza Group AG
2.72%
Roivant Sciences Ltd.
2.58%
Cencora, Inc.
2.55%
Frequently asked questions about BBH and GDOC
How have the BBH and GDOC ETFs performed in 2026?
As of November 5, 2026, BBH is up 32.7% year-to-date (YTD), while GDOC has returned 11.35%. That puts BBH better performer ahead so far this year.
Which ETF is attracting more investor money: BBH or GDOC?
Year-to-date, the BBH ETF saw +$22M in flows, compared to -$2M for GDOC.
Which ETF is more volatile: BBH or GDOC?
Over the past year, BBH had a volatility of 22.89%, while GDOC experienced 15.9%.
Which ETF is bigger: BBH or GDOC?
As of November 5, 2026, BBH holds $518.81 M in assets under management (AUM), while GDOC manages $20.83 M.
What sectors do the BBH and GDOC ETFs invest in?
BBH leans toward sectors like Healthcare. Meanwhile, GDOC focuses on Healthcare.
What are the top holdings of the BBH ETF and GDOC ETF?
BBH top holdings include Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc.. GDOC holds in its top three: Eli Lilly & Co., Johnson & Johnson and Merck & Co., Inc..
Which ETF is more diversified: BBH or GDOC?
BBH holds 25 securities with 85.93% of its assets in the top 15. GDOC has 37 securities and a top 15 weight of 72.21%.
Advertisement
Advertisement
